Innate immunity and disorders of the female reproductive tract
- 1 June 2008
- journal article
- review article
- Published by Bioscientifica in Reproduction
- Vol. 135 (6), 739-749
- https://doi.org/10.1530/rep-07-0564
Abstract
Sexually transmitted infections, and their associated sequelae, such as tubal infertility, ectopic pregnancy and preterm labour, are a major worldwide health problem.Chlamydia trachomatisinfection is thought to be the leading global cause of tubal infertility and tubal ectopic pregnancy. Preterm birth occurs in around 10% of all deliveries, and nearly 30% of preterm deliveries are associated with intrauterine infection. The mucosal innate immune system of the female reproductive tract has evolved to eliminate such sexually transmitted pathogens whilst maintaining its ability to accommodate specialized physiological functions that include menstruation, fertilization, implantation, pregnancy and parturition. The aim of this review was to describe the role and distribution of key mediators of the innate immune system, the natural antimicrobial peptides (secretory leukocyte protease inhibitor, elafin and the defensins) and the pattern recognition toll-like receptors in the normal female reproductive tract and in the context of these pathological processes.Keywords
This publication has 99 references indexed in Scilit:
- Reversible Deficiency of Antimicrobial Polypeptides in Bacterial VaginosisInfection and Immunity, 2006
- Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarumCellular Microbiology, 2006
- Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranesAmerican Journal of Obstetrics and Gynecology, 2004
- Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitisAmerican Journal of Obstetrics and Gynecology, 2004
- Up-Regulation of Secretory Leukocyte Protease Inhibitor (SLPI) in the Brain after Ischemic Stroke: Adenoviral Expression of SLPI Protects Brain from Ischemic InjuryMolecular Pharmacology, 2003
- Effect of Menstrual Status on Antibacterial Activity and Secretory Leukocyte Protease Inhibitor Production by Human Uterine Epithelial Cells in CultureThe Journal of Infectious Diseases, 2002
- Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.JCI Insight, 1996
- Ectopic pregnancy and Chlamydial serologyInternational Journal of Gynecology & Obstetrics, 1993
- On the nature and function of human uterine granular lymphocytesImmunology Today, 1991
- Elafin is a potent inhibitor of proteinase 3Biochemical and Biophysical Research Communications, 1991